Discovery of biomarkers in rare diseases

The journal EPMA has published an article about biomarkers in rare diseases. There are more than 8000 rare diseases that affect >5% of the world’s population. Many of the RDs have no effective treatment and lack the knowledge creates delayed diagnosis making management difficult. The emerging concept of the personalized medicine allows for early screening, diagnosis, and individualized treatment of human diseases. In this context, the discovery of biomarkers in RDs will be of prime importance to enable timely prevention and effective treatment. The full-text of the article you can find here.